Merial GALLIMUNE® FLU H5N9 - Avian Influenza / Bird Flu Vaccine

Merial.com Merial Avian Products Contact Us

Country Sites

Home
About AI

Vaccination Technology
Hatchery Equipment
Field Equipment

GALLIMUNE™ FLU H5N9
GALLIVAC™ Se
TROVAC™ - AIV H5
More Soon

Characteristics of Gallimune Flu H5N9

Proven, inactivated vaccine technology
Developed from a strain tested at independent laboratories in the USA and Australia
Complies with OIE guidelines
Developed in response to the Asian AI outbreaks

Features & Benefits
Contains H5N9 strain of AI
The hemagglutinin type that is involved in the current Asian outbreak
An unusual neuraminidase type that differs from the field strains in the current Asian outbreak
Allows use of the neuraminidase based DIVA testing methodology
Uses a 0.2 ml dose in broilers and a 0.3 ml dose in pullets
Low volume dose for easier, more accurate vaccine administration
Made with a well characterized low pathogenic AI strain
As recommended in OIE guidelines
Safer than unregulated vaccines made from
highly pathogenic or uncharacterized AI strains

Summary of Product Characteristics

Coming Soon

GENERAL REMINDER:
Usage instructions & withdrawal periods may vary by Country.
Always follow label instructions. If in any doubt consult your veterinarian.

NOTE: Advertisments and/or reference to commercial products or trade names within information provided by ThePoultrySite.com does not constitute an endorsement by ThePoultrySite.com and does not imply discrimination against any other similar products.

Monday 7th July